4
Changes in Ownership
Seres Therapeutics, Inc. Filed Acc 0000899243-21-024989
Options or other derivatives
- Director acquired 23,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Zausner Meryl · Director
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2021-06-16 | Grant or award : show line 1 in the form Stock Option (right to buy) | +23,000 | 23,000 | D |
Loading xslF345X03/doc4.xml…